2019
DOI: 10.1016/j.jaccao.2019.11.008
|View full text |Cite
|
Sign up to set email alerts
|

Biventricular Dysfunction in Patients After Bone Marrow Transplant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…Similarly, for OS, high levels of serum ferritin were significantly associated with poor outcomes [ 12 ], but the same was not true for GLS. Anthracycline is widely used to treat hematologic malignancies and is known to cause chemotherapy‐related cardiac dysfunction (CTRCD) [ 13 , 14 ]. In our study, patients who had received ≥200 anthracycline had a tendency to develop more cardiac events ( p = 0.06).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, for OS, high levels of serum ferritin were significantly associated with poor outcomes [ 12 ], but the same was not true for GLS. Anthracycline is widely used to treat hematologic malignancies and is known to cause chemotherapy‐related cardiac dysfunction (CTRCD) [ 13 , 14 ]. In our study, patients who had received ≥200 anthracycline had a tendency to develop more cardiac events ( p = 0.06).…”
Section: Discussionmentioning
confidence: 99%
“…Several studies on GLS in allogeneic HSCT recipients have been reported [ 14 , 15 ]; however, much remains to be elucidated regarding long‐term cardiac follow‐up with GLS. Recent studies have shown that GLS is a more sensitive parameter than EF for evaluating cardiac function in patients with heart failure or CTRCD [ 6 , 7 , 16 ].…”
Section: Discussionmentioning
confidence: 99%